A detailed history of Calamos Advisors LLC transactions in Mannkind Corp stock. As of the latest transaction made, Calamos Advisors LLC holds 184,661 shares of MNKD stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
184,661
Previous 315,682 41.5%
Holding current value
$1.12 Million
Previous $1.98 Million 40.11%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

SELL
$5.93 - $7.44 $776,954 - $974,796
-131,021 Reduced 41.5%
184,661 $1.19 Million
Q3 2024

Nov 07, 2024

BUY
$5.01 - $6.7 $1.58 Million - $2.12 Million
315,682 New
315,682 $1.98 Million

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.57B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.